McLeod HL - Search Results

1

Analysis of the dihydropyrimidine dehydrogenase polymorphism in a British population.

McMurrough J, McLeod HL. McMurrough J, et al. Among authors: mcleod hl. Br J Clin Pharmacol. 1996 May;41(5):425-7. doi: 10.1046/j.1365-2125.1996.34212.x. Br J Clin Pharmacol. 1996. PMID: 8735686 Free PMC article.

2

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.

Amstutz U, Henricks LM, Offer SM, Barbarino J, Schellens JHM, Swen JJ, Klein TE, McLeod HL, Caudle KE, Diasio RB, Schwab M. Amstutz U, et al. Among authors: mcleod hl. Clin Pharmacol Ther. 2018 Feb;103(2):210-216. doi: 10.1002/cpt.911. Epub 2017 Nov 20. Clin Pharmacol Ther. 2018. PMID: 29152729 Free PMC article.

3

Thiopurine methyltransferase activity in American white subjects and black subjects.

McLeod HL, Lin JS, Scott EP, Pui CH, Evans WE. McLeod HL, et al. Clin Pharmacol Ther. 1994 Jan;55(1):15-20. doi: 10.1038/clpt.1994.4. Clin Pharmacol Ther. 1994. PMID: 8299312

4

MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity.

Ameyaw MM, Regateiro F, Li T, Liu X, Tariq M, Mobarek A, Thornton N, Folayan GO, Githang'a J, Indalo A, Ofori-Adjei D, Price-Evans DA, McLeod HL. Ameyaw MM, et al. Among authors: mcleod hl. Pharmacogenetics. 2001 Apr;11(3):217-21. doi: 10.1097/00008571-200104000-00005. Pharmacogenetics. 2001. PMID: 11337937

5

Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia.

McLeod HL, Krynetski EY, Relling MV, Evans WE. McLeod HL, et al. Leukemia. 2000 Apr;14(4):567-72. doi: 10.1038/sj.leu.2401723. Leukemia. 2000. PMID: 10764140 Review.

6

Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia.

McLeod HL, Coulthard S, Thomas AE, Pritchard SC, King DJ, Richards SM, Eden OB, Hall AG, Gibson BE. McLeod HL, et al. Br J Haematol. 1999 Jun;105(3):696-700. doi: 10.1046/j.1365-2141.1999.01416.x. Br J Haematol. 1999. PMID: 10354134

7

The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.

Collie-Duguid ES, Pritchard SC, Powrie RH, Sludden J, Collier DA, Li T, McLeod HL. Collie-Duguid ES, et al. Among authors: mcleod hl. Pharmacogenetics. 1999 Feb;9(1):37-42. doi: 10.1097/00008571-199902000-00006. Pharmacogenetics. 1999. PMID: 10208641

8

Thiopurine methyltransferase alleles in British and Ghanaian populations.

Ameyaw MM, Collie-Duguid ES, Powrie RH, Ofori-Adjei D, McLeod HL. Ameyaw MM, et al. Among authors: mcleod hl. Hum Mol Genet. 1999 Feb;8(2):367-70. doi: 10.1093/hmg/8.2.367. Hum Mol Genet. 1999. PMID: 9931345

9

Ethnic differences in catechol O-methyltransferase pharmacogenetics: frequency of the codon 108/158 low activity allele is lower in Kenyan than Caucasian or South-west Asian individuals.

McLeod HL, Syvänen AC, Githang'a J, Indalo A, Ismail D, Dewar K, Ulmanen I, Sludden J. McLeod HL, et al. Pharmacogenetics. 1998 Jun;8(3):195-9. Pharmacogenetics. 1998. PMID: 9682265

10

Phase I dose-escalation and pharmacokinetic study of a novel folate analogue AG2034.

Bissett D, McLeod HL, Sheedy B, Collier M, Pithavala Y, Paradiso L, Pitsiladis M, Cassidy J. Bissett D, et al. Among authors: mcleod hl. Br J Cancer. 2001 Feb 2;84(3):308-12. doi: 10.1054/bjoc.2000.1601. Br J Cancer. 2001. PMID: 11161393 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results